Vivacaine Injection, Solution
Product Images NDC 0362-9011

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Vivacaine (NDC 0362-9011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Septodont, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2380 7 B200 Vivacaine Us Pc Gtin

2380 7 B200 Vivacaine Us Pc Gtin
Vivacaine® is a type of injection that contains Bupivacaine Hydrochloride and Epinephrine. The concentration of the medication is either 0.3% or 0.5%. The package includes a warning that the injection contains sulfites. One of the applications of Vivacaine is for dental use. The provided text includes several product codes and numerical IDs but lacks a coherent description.*
FDA Label Image

Bupivacaine Hydrochloride

FDA Label Image

Epinephrine Bitartrate

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.